Literature DB >> 6824501

Seizure after pulse therapy with methyl prednisolone.

A L Suchman, J J Condemi, J P Leddy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6824501     DOI： 10.1002/art.1780260123

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  9 in total

Review 1.  Combination treatment in autoimmune diseases: systemic lupus erythematosus.

Authors:  G Moroni; O Della Casa Alberighi; C Ponticelli
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats.

Authors:  Imam H Shaik; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2012-07-24       Impact factor: 3.534

4.  A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

Authors:  J C Edwards; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

Review 5.  Current treatment recommendations for lupus nephritis.

Authors:  C Ponticelli
Journal:  Drugs       Date:  1990-07       Impact factor: 9.546

6.  Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.

Authors:  Suman Penugonda; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.

Authors:  Anjaneya P Chimalakonda; Donald L Montgomery; Jon A Weidanz; Imam H Shaik; Justin H Nguyen; John J Lemasters; Eiji Kobayashi; Reza Mehvar
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

8.  Combination of methylprednisolone pulse therapy and remission inducing drugs in rheumatoid arthritis.

Authors:  T M Hansen; E Dickmeiss; H Jans; T Ingemann Hansen; M Ingeman-Nielsen; I Lorenzen
Journal:  Ann Rheum Dis       Date:  1987-04       Impact factor: 19.103

9.  Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

Authors:  I A Williams; A D Mitchell; W Rothman; P Tallett; K Williams; P Pitt
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.